mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.009 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.009 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.009 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.009 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |